Centre launches drug registry to standardise medicine data

IMT News Desk
IMT News Desk
· 1 min read
Centre launches a drug registry under ABDM to standardise medicine data, improve interoperability and strengthen digital health in India.

The Union Health Ministry has launched a Drug Registry under the Ayushman Bharat Digital Mission to standardise medicine-related information across India’s healthcare ecosystem. The registry is intended to act as a single source of verified drug information, helping improve consistency in how medicines are identified, stored, exchanged and used across digital health systems.

Built in collaboration with the Central Drugs Standard Control Organization and the National Resource Centre for EHR Standards, the registry uses standard coding frameworks to support interoperability. It currently covers generic medicines, branded drugs and substances, and is designed to strengthen prescribing, dispensing and health data exchange across the country.

Officials said the platform will improve transparency, trust and data quality in healthcare delivery. It is also part of a wider effort to build common digital standards for India’s health ecosystem and make health information easier to share across systems.

Read Next

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk
India-UK FTA Opens Medical Device Trade, but Industry Wants Stronger Safeguards on Third-Country Rerouting
News
July 16, 2026

India-UK FTA Opens Medical Device Trade, but Industry Wants Stronger Safeguards on Third-Country Rerouting

The India-UK Comprehensive Economic and Trade Agreement has created a more favourable framework for medical device trade by paving the way for regulatory recognition and improved market access. Still, industry players are urging stronger safeguards to prevent third-country rerouting. The concern is that products from non-FTA countries, especially China, could be routed through the UK […]
Article by: IMT News Desk
Manipal Hospital, Millers Road Launches Sports Injury Care Centre for Specialised Knee and Shoulder Care
News
July 15, 2026

Manipal Hospital, Millers Road Launches Sports Injury Care Centre for Specialised Knee and Shoulder Care

 As participation in sports and fitness activities continues to rise across India, sports-related injuries are becoming increasingly common among both professional athletes and recreational fitness enthusiasts. Addressing this growing healthcare need, Manipal Hospital Millers Road has launched its dedicated Sports Injury Care Centre, offering specialised diagnosis and treatment for knee and shoulder injuries through advanced […]
Article by: IMT News Desk